There are an estimated 48,000 new cases of Stomach and Esophageal Cancer in the U.S. each year. Each year, an estimated 27,500 are terminal.

2 of 3 people diagnosed with Stomach and Esophageal Cancers are not diagnosed until Stage 4.

Yet, less than 1% of the cancer research funded by NIH goes towards gastroesophageal cancer.

For every $1 donated, $12 is generated in follow-on funding; turning research into action.

In 17 years, DFF has funded 29 grants for a total of more than $7.9 million.

Those grants have received $45.6 million in follow-on funding.

Nine of those Grants received follow-on funding from the by NIH, where only approximately 5% of NIH applicants for gastroesophageal cancer research receive funding.

One of the Grants received the very prestigious Starr Foundation Grant for just under $1 million - it was a collaborative grant with Dana Farber and MSKCC led by Dr Shah.

Early diagnosis is key.

Stage 1 has a 49 to 75% survival rate. Unfortunately, symptoms arise around stage 4 where the survival rate is 6%.

DFF is dedicated to facilitating collaborative research on the pathogenesis, early diagnosis, and treatment of Upper GI Malignancies.

1. 100% of DFF funds go directly to research.
2. DeGregorio Family Foundation Scientific Advisory Board look for the best research that will attract follow-on funding.
3. Grant recipients provide progress reports, and attract follow-on funding to implement their research.
4. Doctors use research for early diagnosis

Click Here

Learn About